In this video, we'll teach you how to optimize your SEO.
If you're a doctor looking to improve your website traffic and rank in search, this video is for you! By following the tips in this video, you'll be able to improve your website's visibility and reach new patients who need your help!
Dr. Maurice Rawlings, MD, a heart surgeon, has written a number of books on the near-death experience and clearly shows from his own practice and the experiences of his patients, that not everyone goes to the light when they die, where there is total love. He has written of many patients being resuscitated on the operating table and speaking about being in hell, where there was a real devil and demons, and where the inhabitants were tormented with fire. Dr. Rawlings writes that these people are a lot more reluctant to talk about it than those who went to the good place. DivineRevelations.info
The Center For Aesthetics https://thecenterforaesthetics.com ~ 800-575-8337 ~ "True beauty shines from the inside out." Dr. Catherine Durboraw shares the story and passion of CFA Beauty premier aesthetic medical centers in Scottsdale, Jackson Hole, Idaho Falls.
The first thing Cathy’s long-time patients say is that they feel seen: “She really sees me. She studies my face carefully and helps me imagine what’s possible.” The first meeting, and each one after is distinguished by a patients-first devotion. We’re your partner all along the journey.
CFA Beauty
Medical Spa & Plastic Surgery
https://thecenterforaesthetics.com/
NEW YORK, NY (January 28, 2019) – Today, CancerCare celebrated its 75th anniversary by revealing a new campaign “If It Matters To You, It Matters To Us.” The campaign declares CancerCare’s commitment to holistic, patient-centered support services, and celebrates a legacy of comprehensive care for people living with cancer.
“A cancer diagnosis turns a person’s life upside down. Throughout many doctors’ visits, tests and treatments, people with cancer often feel like they’re perceived as a patient rather than a person,” said CancerCare CEO, Patricia Goldsmith. “For 75 years, CancerCare has championed the importance of addressing what matters most to patients and their families through free, direct services to help cope with the emotional, practical and financial challenges of a cancer diagnosis.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8350251-cancercare-75th-anniversary-cancer-community/
GB Sciences, Inc. (OTCQB: GBLX) announces the success of its first annual, “Innovation in Medical Cannabis Therapies” (IMCT) Symposium, held on Friday, November 9th at the “Keep Memory Alive” Event Center at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, Nevada. Throughout the day’s program, there was an emerging sense of heightened responsibility on the part of the cannabis industry to better address medical cannabis patients' needs through research and development of medical cannabis products that are better standardized, more easily-dosed, and made more widely-available to cannabis patients at a fair price.
To view the multimedia release go to:
https://www.multivu.com/players/English/8308958-gb-sciences-2018-medical-cannabis-therapies-symposium/
Doctors at Qatar’s first specialist women’s and children’s hospital Sidra Medicine have successfully separated conjoined twins, marking a first for the country. The surgery establishes an alternative for patients who previously had limited choices for the successful treatment and care of complex pediatric diseases in the region.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8422651-conjoined-twins-find-new-lease-on-life/
LG Chem, la division chimie de LG Group, a signé un partenariat de distribution exclusif pour la France et la Belgique avec Laboderm - filiale de Novomed Group spécialisée en dermatologie et médecine esthétique - pour la distribution de sa gamme YVOIRE, génération innovante de produits de comblement injectables à base d’acide hyaluronique (AH) réticulé d’origine non-animale.
La gamme YVOIRE révolutionne l’offre des produits de comblement. Sa technologie exclusive « HICE » (High Concentration Equalized) se caractérise d’un côté par un haut poids moléculaire pour un effet plus durable et une plus forte élasticité, et de l’autre par une très faible concentration d’agent réticulant BDDE (Butyl Diglycidyl Ether), garantissant plus de sécurité. Au total, sa composition résulte en des produits homogènes, faciles à injecter (fluidité et régularité) et plus résistants à la dégradation enzymatique.
La gamme se décline en trois catégories de produits (« Classic », « Volume », « Contour ») avec ou sans lidocaïne (pour plus de confort), offrant aux praticiens de larges possibilités d’interventions personnalisées selon les patients.
To view the multimedia release go to:
https://www.multivu.com/players/fr/8392651-lg-chem-laboderm-distributeur-yvoire/
Cancer Treatment Centers of America® (CTCA), a national network of comprehensive cancer care hospitals and outpatient care centers, and Foundation Medicine, a leading molecular insights company that recently received FDA approval for its FoundationOne CDx™ genomic test, today announced the launch of a collaborative educational campaign designed to heighten awareness of the promise of precision medicine and the role that advanced genomic testing plays in helping identify treatments best suited for individual patients.
To view the multimedia release go to:
https://www.multivu.com/players/English/8295651-cancer-treatment-centers-of-america-foundation-medicine-precision-cancer-treatment/
Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W. L. Gore & Associates, Inc. (Gore) has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication for its GORE® CARDIOFORM Septal Occluder. The device, already approved for closure of atrial septal defects (ASDs) up to 17 mm, is now also approved for the closure of PFO to reduce the risk of recurrent ischemic stroke in certain patients.*
To view the multimedia release go to:
https://www.multivu.com/players/English/8301551-gore-cardioform-septal-occluder-fda-approval/
Having lost his mother to the disease, singer, songwriter Gavin DeGraw knows firsthand how devastating pancreatic cancer is for patients and their families. Gavin is turning his grief into action by helping the Lustgarten Foundation raise awareness by encouraging people to get involved with the Foundation.
“My mother didn’t make it and unfortunately right now that’s a common story. But it doesn’t have to be the story permanently,” DeGraw said. “By funding research, the Lustgarten Foundation is going to change the course of this disease. I encourage everyone to get involved in some way – join a walk or make a donation.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213753-lustgarten-foundation-pancreatic-cancer-awareness/
Abbott today announced the U.S. Food and Drug Administration (FDA) approved the Masters HP™ 15mm rotatable mechanical heart valve, the world’s smallest mechanical heart valve, that will allow doctors to treat babies and toddlers in need of a mitral or aortic valve replacement. Until today, surgeons could only use a range of larger-sized valves to replace a pediatric heart valve that could not be repaired, and larger valves are often not suitable given the smaller size of children’s hearts. This dime-sized new valve is the first and only pediatric mechanical heart valve developed for newborns and infants, and offers hope for pediatric patients in urgent need of treatment who have no other approved options.
To view the multimedia release go to:
https://www.multivu.com/players/English/8280551-abbott-pediatric-heart-valve-fda-approval/
The ImplantCenter has recently opened the brand-new operating room suited for more complex treatments. This comes alongside numerous additions such as the launch of the four cosy apartments to rest after treatments at the clinic and an implant education facility to expand their services further. These expansions are part of constant improvements that have been occurring for the last 15 years, alongside high quality service.
The area of the clinic has increased by ten-fold to approximately 1800 m2 during the years. Moreover, the oral surgery division was opened in 2015, so eight dental treatment rooms and four oral surgery rooms are now in place today. All of the surgery rooms can serve ambulatory oral surgery treatments. The ImplantCenter is unique in Hungarian private dentistry because they can implement more complex treatments in the framework of one-day oral surgery procedure. This is due to the big and fully equipped operating room opened in November 2017. As part of the service, the ImplantCenter offers one and two-bed private rooms with medical supervision to their patients after each surgery.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8274651-implantcenter-hungarian-dental-service/
